Zydus gets USFDA Fast Track for oral inhibitor Usnoflast
29 May 2025 //
INDPHARMAPOST
Zydus receives FDA Orphan Drug Designation for ALS
23 Jan 2025 //
ECONOMICTIMES
Zydus receives approval to conduct Phase II(b) trial for Usnoflast
20 Jan 2025 //
EXPRESSPHARMA